Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Neuromuscular Disorders : NMD
|
December 1, 1996
Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy
C A Sewry, J Taylor, L V Anderson, et al.
Muscle & Nerve
|
July 9, 1998
Alternative dystrophin gene transcripts in golden retriever muscular dystrophy
S J Schatzberg, L V Anderson, S D Wilton, et al.
Human Molecular Genetics
|
July 1, 1997
Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy
L Metzinger, D J Blake, M V Squier, et al.
Neuromuscular Disorders : NMD
|
March 11, 2000
Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease
M Auranen, J Rapola, H Pihko, et al.
The American Journal of Pathology
|
October 20, 1998
Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A
L V Anderson, K Davison, J A Moss, et al.
Neuroreport
|
March 10, 2001
Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation
E Vafiadaki, A Reis, S Keers, et al.
The Journal of Biological Chemistry
|
September 20, 1996
Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane
H Yamada, A J Denzer, H Hori, et al.
Neuromuscular Disorders : NMD
|
April 9, 2008
Late onset in dysferlinopathy widens the clinical spectrum
L Klinge, A F Dean, W Kress, et al.
Journal of the Neurological Sciences
|
March 10, 1997
Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A)
M J Spencer, J G Tidball, L V Anderson, et al.
The Journal of Biological Chemistry
|
May 23, 1997
A role of dystroglycan in schwannoma cell adhesion to laminin
K Matsumura, A Chiba, H Yamada, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Neuromuscular Disorders : NMD
|
December 1, 1996
Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy
C A Sewry, J Taylor, L V Anderson, et al.
Muscle & Nerve
|
July 9, 1998
Alternative dystrophin gene transcripts in golden retriever muscular dystrophy
S J Schatzberg, L V Anderson, S D Wilton, et al.
Human Molecular Genetics
|
July 1, 1997
Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy
L Metzinger, D J Blake, M V Squier, et al.
Neuromuscular Disorders : NMD
|
March 11, 2000
Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease
M Auranen, J Rapola, H Pihko, et al.
The American Journal of Pathology
|
October 20, 1998
Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A
L V Anderson, K Davison, J A Moss, et al.
Neuroreport
|
March 10, 2001
Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation
E Vafiadaki, A Reis, S Keers, et al.
The Journal of Biological Chemistry
|
September 20, 1996
Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane
H Yamada, A J Denzer, H Hori, et al.
Neuromuscular Disorders : NMD
|
April 9, 2008
Late onset in dysferlinopathy widens the clinical spectrum
L Klinge, A F Dean, W Kress, et al.
Journal of the Neurological Sciences
|
March 10, 1997
Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A)
M J Spencer, J G Tidball, L V Anderson, et al.
The Journal of Biological Chemistry
|
May 23, 1997
A role of dystroglycan in schwannoma cell adhesion to laminin
K Matsumura, A Chiba, H Yamada, et al.
Page
of 5